The impact of genomics to identify novel immunotherapeutic targets in multiple myeloma

被引：0
|
作者：
Liu, Enze [1 ]
Sudha, Parvathi [1 ]
Abu Zaid, Mohammad [1 ]
Johnson, Travis [2 ]
Chopra, Vivek [3 ]
Dos Santos, Cedric [3 ]
Nixon, Michael [3 ]
Hamidi, Habib [3 ]
Suvannasankha, Attaya [4 ,5 ]
Lee, Kelvin [1 ]
Abonour, Rafat [6 ]
Walker, Brian [1 ]
机构：
[1] Indiana Univ, Sch Med, Div Hematol & Oncol, Melvin & Bren Simon Comprehens Canc Ctr, Indianapolis, IN 46204 USA
[2] Indiana Univ, Sch Med, Dept Biostat & Hlth Data Sci, Indianapolis, IN USA
[3] Genentech Inc, San Francisco, CA 94080 USA
[4] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA
[5] Roudebush VAMC, Indianapolis, IN USA
[6] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OA-32
引用
收藏
页码：S19 / S20
页数：2
相关论文
共 50 条
  • [21] Genomics of Multiple Myeloma
    du Pont, Sebastien Robiou
    Cleynen, Alice
    Fontan, Charlotte
    Attal, Michel
    Munshi, Nikhil
    Corre, Jill
    Avet-Loiseau, Herve
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (09) : 963 - 967
  • [22] Genomics in Multiple Myeloma
    Munshi, Nikhil C.
    Avet-Loiseau, Herve
    CLINICAL CANCER RESEARCH, 2011, 17 (06) : 1234 - 1242
  • [23] CircRNAs: novel therapeutic targets in multiple myeloma
    Xinyi Zhou
    Juan Du
    Molecular Biology Reports, 2022, 49 : 10667 - 10676
  • [24] Immunotherapeutic and Targeted Approaches in Multiple Myeloma
    Nadeem, Omar
    Tai, Yu-Tzu
    Anderson, Kenneth C.
    IMMUNOTARGETS AND THERAPY, 2020, 9 : 201 - 215
  • [25] Identification of Metabolic Enzymes ENO1 and KMO As Novel Immunotherapeutic Targets in Myeloma
    Ray, Arghya
    Das, Deepika S.
    Song, Yan
    Chauhan, Dharminder
    Anderson, Kenneth C.
    BLOOD, 2017, 130
  • [26] Immunotherapeutic approaches to treat multiple myeloma
    Roeven, Mieke W. H.
    Hobo, Willemijn
    Schaap, Nicolaas
    Dolstra, Harry
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (04) : 896 - 910
  • [27] Decoding the Pathophysiology and the Genetics of Multiple Myeloma to Identify New Therapeutic Targets
    Lawasut, Panisinee
    Groen, Richard W. J.
    Dhimolea, Eugen
    Richardson, Paul G.
    Anderson, Kenneth C.
    Mitsiades, Constantine S.
    SEMINARS IN ONCOLOGY, 2013, 40 (05) : 537 - 548
  • [28] GENOMICS OF MULTIPLE MYELOMA INFLUENCES THE EXPRESSION OF CAR T-CELL TARGETS
    Yu, Christina
    Walker, Brian
    Roodman, G. David
    Huang, Kun
    Sadelain, Michel
    Perna, Fabiana
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A83 - A83
  • [29] GENOMICS OF MULTIPLE MYELOMA DICTATES THE EXPRESSION OF CAR T-CELL TARGETS
    Yu, Christina
    Walker, Brian
    Roodman, David
    Huang, Kun
    Sadelain, Michel
    Perna, Fabiana
    EXPERIMENTAL HEMATOLOGY, 2020, 88 : S85 - S85
  • [30] Low Dose Cyclophosphamide in Combination with Elotuzumab - a Novel Immunotherapeutic Strategy for Multiple Myeloma
    Feerick, Claire L.
    Lynch, Kevin
    Krawczyk, Janusz
    O'Dwyer, Michael
    Ryan, Aideen
    BLOOD, 2021, 138
12345